Novel methods to improve detection and outcomes of prostate cancer
Poster Session 26
-
Location:Room Stockholm, North Hall (Level 1)
-
Chairs:
-
Aims and objectives of this session The aim of this session is to provide an update on novel approach to improve detection and outcomes of prostate cancer.
- Poster viewing of 20 minutes. Presentations will take place on stage. Standard presentations are 2 minutes in length, followed by 2 minutes for discussion. Extended presentations (*) are 3 minutes in length, followed by 3 minutes for discussion.
Institutes: 1Tampere University Hospital, Dept. of Urology, Tampere, Finland, 2University of Tampere, School of Medicine, Tampere, Finland, 3Fimlab Laboratories, Dept. of Pathology, Tampere, Finland, 4Satakunta Central Hospital, Dept. of Urology, Pori, Finland, 5Päijät-Häme Central Hospital, Dept. of Urology, Lahti, Finland
Institutes: 1Chungbuk National University, Dept. of Urology, Cheongju, South Korea, 2Chungbuk National University Hospital, Office of Public Health, Cheongju, South Korea, 3College of Medicine, Chungbuk National University, Dept. of Preventive Medicine, Cheongju, South Korea, 4National Police Hospital, Dept. of Urology, Seoul, South Korea, 5Chungbuk National University College of Medicine, Dept. of Urology, Cheongju, South Korea, 6Kyungpook National University Medical Center, Dept. of Urology, Daegu, South Korea
Institutes: 1Hirosaki University Graduate School of Medicine, Dept. of Urology, Hirosaki, Japan, 2Wako Pure Chemical Industries, Ltd., Diagnostics Research Laboratories, Amagasaki, Japan
Institutes: 1Complejo Hospitalario Universitario Granada, Dept. of Urology, Granada, Spain, 2Pfizer-University of Granada-Junta De Andalucía Centre For Genomics and Oncological Research (GENYO), Dept. of Genomics, Granada, Spain
Institutes: 1La Fe, Universitary and Polytechnic Hospital, Dept. of Urology, Valencia, Spain, 2Insituto De Investigación Sanitaria La Fe, Grupo De Hemostasia, Trombosis, Arteriosclerosis Y Biología Vascular, Valencia, Spain
Institutes: 1University of Toronto, University Health Network, Dept. of Surgical Oncology, Division of Urology, Toronto, Canada, 2University of Toronto, University Health Network and Sinai Health System, Dept. of Surgical Oncology, Division of Urology, Toronto, Canada
Institutes: 1Kaiser Permanente Northern California, Dept. of Research, Oakland, United States of America, 2Kaiser Oakland Medical Center, Dept. of Pathology, Oakland, United States of America, 3Genomic Health, Dept. of Pathology, Redwood City, United States of America, 4Genomic Health, Dept. of Biostatistics, Redwood City, United States of America, 5Genomic Health, Medical Department, Redwood City, United States of America, 6Kaiser Oakland Medical Center, Dept. of Urology, Oakland, United States of America
Institutes: 1Sant’Andrea Hospital – Sapienza University, Dept. of Urology, Rome, Italy, 2Padre Pio Da Pietrelcina Hospital, Dept. of Urology, Vasto, Italy, 3General Hospital of Veria, Dept. of Urology, Veria, Greece, 4Aristotle University of Thessaloniki, Dept. of Urology, Thessaloniki, Greece, 5Careggi Hospital, Dept. of Urology, Florence, Italy
Institutes: 1Kings College London, Innate Immunity, MRC Centre for Transplantation, London, United Kingdom, 2Kings College London, Cancer Epidemiology Group, Division of Cancer Sciences, London, United Kingdom, 3Kings College London, KHP Cancer Biobank, 3rd Floor Bermondsey Wing Guy’s Hospital, London, United Kingdom, 4Kings College London, MRC Centre for Transplantation, and Urology Centre, London, United Kingdom
Institutes: 1Mount Sinai Hospital, Dept. of Surgery (urology), Toronto, Canada, 2Mount Sinai Hospital, Lunenfeld-Tanenbaum Research Institute, Toronto, Canada, 3Cantonal Hospital Aarau, Dept. of Urology, Aarau, Switzerland, 4Ontario Institute For Cancer Research, Informatics & Biocomputing Program, Toronto, Canada, 5Princess Margaret Hospital, University Health Network, Dept. of Surgical Oncology, Urology, Toronto, Canada, 6Mount Sinai Hospital, Dept. of Surgery and Urology, Toronto, Canada, 7Memorial University, Craig L. Dobbin Genetics Research Centre, Discipline of Genetics, Faculty of Medicine, St. John’s, Canada, 8Mount Sinai Hospital, Dept. of Surgery, Urology, Toronto, Canada, 9Mount Sinai Hospital, Dept. of Pathology and Laboratory Medicine, Toronto, Canada, 10Princess Margaret Hospital, University Health Network, Ontario Cancer Institute, Toronto, Canada, 11Toronto General Hospital, University Health Network, Dept. of Pathology, Toronto, Canada